The 13 states where Medicaid covers GLP-1 drugs for obesity are California, Kansas, Minnesota, Wisconsin, Michigan, Mississippi, Pennsylvania, Virginia, North Carolina, Massachusetts, New Hampshire, Delaware and Rhode Island
10.1038/s41522-024-00477-w 51 LebherzC.SchlieperG.MollmannJ.KahlesF.SchwarzM.BrunsingJ.et al (2017)
If cost is part of what's holding you back from starting, here's a full breakdown of what GLP-1 treatment actually costs and what's included at HealthiCare
30 A total of 711 patients with T2DM (mean baseline A1C of approximately 8% in all treatment groups) were enrolled and randomized to receive one of three interventions: 1) 14 mg daily of oral semaglutide
Four datapoints were excluded for one cage in vehicle group due to food spillage on day 11-14
Large-scale clinical trials, including cardiovascular outcome studies, have not identified increased fracture risk as a prominent adverse effect of GLP-1 therapy